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The major histocompatibility complex (H-2) of the mouse codes for two major 
classes of cell surface structures, the classical transplantation antigen of the K 
and D regions and the Ia antigens, which are products of genes mapping in the I 
(immune response) region (for review, reference 1). In contrast to the wide tissue 
distribution of the  H-2K and  H-2D  major histocompatibility antigens,  the  Ia 
antigens have a restricted distribution with principal expression on subpopula- 
tions of T  and B  lymphocytes (2-8). The mapping of such important immune 
functions as mixed lymphocyte reaction, graft versus host reactivities, immune 
response control (It genes), and cell-cell interaction determinants to the I region 
has stimulated efforts to identify possible relationships between Ia determinants 
and these immune functions (9-14). 
In recent experiments, we have been able to show inhibition of the primary 
and secondary in vitro responses to heterologous erythrocytes by a brief incuba- 
tion of the spleen cells with anti-Ia sera in the absence of complement before 
culturing the  cells  with  antigen  (15).  This inhibition was  not observed with 
antisera  against  H-2K  or H-2D  determinants.  These  anti-Ia  sera  were  also 
capable of significantly inhibiting the proliferative response of B lymphocytes to 
the mitogen lipopolysaccharide (LPSP (16). Similar inhibition was not observed 
with anti-H-2K antibodies. Pretreatment of the B-lymphocyte population with 
anti-Ia serum and complement eliminated the LPS-responsive cells (16). In this 
report we have used appropriate anti-Ia sera to determine whether Concana- 
valin A  (Con-A)-  and  Phytohemagglutinin (PHA)-sensitive T  cells were  con- 
tained in the subpopulation of Ia positive T cells. 
Material and Methods 
Mice.  B10.Br  (H-2  k) mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. 
All  other  mice were maintained  in  Dr.  Niederhuber's and/or Dr.  Shreffler's colony at  The 
University of Michigan. 
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Antisera.  Anti-Ia sera were prepared, as previously described, by reciprocal immunization of 
A.TH (H-2  ~) and A.TL (H-2 tl) mice (2). A.TH anti-A.TL (Ia  k) and A.TL anti-A.TH (Ia  ~) sera have 
been extensively characterized by  cytotoxic  and  absorption tests  and  are  specific for/-region 
determinants (1).  Batches of sera comprising several bleedings from a single series of immuniza- 
tions consistently give a biphasic titration curve in the dye exclusion microcytotoxic test. The high 
plateau of 50-60% spleen cell lysis breaks to a  lower plateau of 20-30% at a  dilution of 1:160 to 
1:320. The lower plateau persists to a titer of 1:1,280 to 1:2,560 (7). Anti-H-2 sera, specific for the H- 
2K  ~  determinant, (H-2.19) were prepared in (A x  A.AL)FI (H-2~/H-2 ~, Thy 1.2) mice against A.TL 
(H-2 ~) cells, and serum specific for H-2K k antigens (H-2.11 and H-2.23) was prepared in A.TL (H- 
2  t~) mice against A.AL (H-2 a~) cells.  Anti-Thy 1.2 serum was prepared by immunizing mice of 
congenic strain A.AKR (H-2 al, Thy-1 °) with A.AL (H-2 ~, Thy-1 b) thymocytes. 
Culture Conditions.  Dispersed spleen cell suspensions were prepared in serum-free RPMI 1640 
media (Microbiological Associates, Bethesda, Maryland) supplemented with 3 ml of HEPES (1 M) 
and 50 ~g/ml ofgentamycin per 100 ml. Con-A was purchased from Calbiochem, San Diego, Calif., 
and PHA-M was obtained from Difco Laboratories, Detroit, Mich. In some experiments, Leucoag- 
glutinin, a highly purified form ofPHA (Pharmacia Fine Chemicals, Uppsala,  Sweden) was used 
to  stimulate cultured  cells. 
Quadruplicate cultures of 5 x  105 viable  lymphoid cells/well  were incubated in multiweU 
Linbro  plates  (Linbro Chemical Co.,  New Haven, Conn.)  for  72  h. During  the last  16  h of  culture, 
0.2  ~Ci  of  [aH]thymidine (2  Ci/mM) was  present  in  the cultures.  The  cultures  were  harvested with 
a multiple  sample harvester (Otto  Hiller  Co.,  Madison, Wis.),  collected  on glass  fiber  filters,  and 
counted in a liquid  scintillation  counter. 
Thymus-derived lymphocytes were prepared  from whole spleen  using nylon wool (LP-1 leuko- 
pak leukocyte filter,  Fenwal Laboratories Inc.,  Morton Grove, Ill.),  as described  by Julius et al. 
(17).  Such cells  are 80-90% Thy-1 positive. 
Antiserum Treatment of  Cells. For blocking experiments, spleen cells  were incubated with 
anti-la  serum  without  complement,  washed  by  centrifugation  in  media,  and  then  cultured.  In  lysis 
experiments, the  cells  were incubated with  appropriate  antisera  in  a dilution  of  1:5  or  1:10  at  37°C 
for  20  rain,  centrifuged,  and  resuspended  in  agarose and  spleen  cell-absorbed  EDTA-treated  rabbit 
complement, diluted  in  RPMI 1640,  and incubated for  30  rain  at  37°C.  The cells  were then  washed 
by  centrifugation  in  media,  counted  in  a hemacytometer,  and  adjusted  to  5 x 106  viable  cells/ml  for 
distribution  at  a  concentration  of  5 x 105  cells  per  culture.  The  final  vol  in  each  culture  was  0.3  ml. 
Results 
Response  of Spleen  Cells Resistant  to  Treatment  with  Anti-Ia  Serum and 
Complement.  When spleen cells from B10.BR (Ia k) mice were incubated with 
A.TH anti-A.TL (anti-Ia k) serum and rabbit complement, approximately 60% of 
the  cells  were  killed,  as  determined  by  trypan  blue  dye  exclusion.  Anti-Ia 
resistant  spleen  cells,  at  a  concentration  of cells  equal  to  control  cultures, 
responded normally  to PHA-M and Leucoagglutinin,  but the  Con-A response 
was only 0-40% of control. The Con-A response was entirely absent in anti-Thy- 
1.2 resistant  spleen  cells  (Table  I,  Fig.  1).  In several  experiments,  the Con-A 
response was not completely eliminated,  even though there was essentially  no 
response by cells  treated  with  anti-Thy-l.2  serum plus complement.  This  ap- 
peared to be the result of insufficient antibodies, since treating the cells a second 
time with anti-Ia serum and complement before culturing eliminated the popula- 
tion sensitive to Con-A. 
Target cells of both H-2 k and H-2" haplotypes were tested with the appropriate 
anti-Ia serum and rabbit complement with identical results (Table I, Fig. 2). In 
some experiments an inappropriate target cell was used as a control. 
Response of Nylon-Wool Purified Splenic T Cells Resistant to Anti-Ia Serum 
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TABLE  I 
Response after Treatment  with Anti-Ia Serum and Complement 
Antiserum and comple-  Reduc-  Exp.  Mitogen  Target cells  [~H]TdR 
ment  tion 
cpm  +- SD  % 
1.  None  B10.BR  (H-2 k)  None  1,652  ±  231 
Spleen cells 
Con A  A.TH-normal serum  51,262  ±  5,630 
A.TH a  A.TL (Ia  k)  17,460  ±  2,230  66 
Anti-Thy 1.2  2,940 ±  558  94 
2.  None  B10.BR  (H-2 k)  None  718 ±  53 
Spleen cells 
Con A  A.TH-normal serum  46,626 ±  2,164 
A.TH a  A.TL (Ia  K)  10,328  ±  1,350  78 
3.  None  B10.S (/-/-2  °)  None  1,968  ±  243 
Spleen cells 
Con A  None  53,470  ±  6,400 
"  A.TL-normal serum  30,126  ±  2,010 
A.TL a  A.TH (Ia  s)  1,953  ±  65  93 
Leucoagglutinin  None  29,129  ±  2,600 
A.TL-normal serum  19,600  ±  1,956 
Leucoagglutinin  A.TL a  A.TH (Ia')  26,025 ±  2,520  7 
4.  None  B10.S (/t-2  ~)  None  2,206 ±  759 
Spleen cells 
Con A  A.TL-normal serum  15,151  ±  1,960 
A.TL a  A.TH (Ia')  1,488  +-  146  90 
5.  None  B10.K (H-2  ~)  None  224 ±  192 
Nylon T cells 
Con A  None  106,259  ±  4,490 
"  A.TH a  A.TL (Ia  k)  8,662  ±  3,358  92 
B10.S (H-2  °)  A.TH a  A.TL (Ia  k)  156,572  ±  10,926  0 
Nylon T cells 
Leucoagglutinin  B10.K (H-2 ~)  None  12,048  ±  1,564 
Spleen 
"  B10.K (H-2  k)  None  13,759  ±  2,566 
Nylon T 
A.TH a  A.TL (Ia  k)  22,732 ±  2,562 
enrichment of Thy-1  positive cells from 30-40% to 80-90%  was obtained.  The 
nylon-wool purified T cells eluted with the first 15 ml of media were responsive 
to Con-A, PHA, and Leucoagglutinin. No LPS response was detected, indicating 
a low B-cell contamination in the purified cell suspensions. 
Purified T cells from B10.K  (H-2 k) and B10.S (H-2')  mice were treated with 
A.TH anti-A.TL (anti-Ia k) serum and rabbit complement. The surviving, anti-Ia 
resistant cells were cultured for 72 h with Con-A and PHA. The anti-Ia resistant 
cell response to Con-A was decreased 10-fold compared to controls treated with 
normal A.TH serum (Fig. 3). No reduction of the Con-A response was observed 
in the control T-cell (B10.S) cultures (Table I).  As previously described for the 
treatment  of intact  spleen  cells,  the  response  of the T  cells to PHA was not NIEDERHUBER  ET  AL.  375 
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FIG. I.  Con-A-stimulated proliferative  response of  BI0.BR (H-2  ~)  spleen cells.  The spleen 
cells  were treated with either normal A.TH serum, A.TH anti-A.TL serum (lak),  or anti- 
Thy-l.2 serum and  rabbit  complement. Equal numbers of  viable  ceils  (5 × 10  ~)  were cultured 
for 72 h with mitogen. The symbols represent: (©--©) normal A.TH serum, (/x_A) A.TH 
anti-A.TL (la  k) serum, and (~Y--V) anti-Thy-l.2 serum. Each point is  the mean counts per 
minute of  four cultures ± SD. 
altered. These experiments were also performed over a  dose range of Con-A of 
0. 5-5 /~g/ml to exclude a shift in the kinetics of the response to Con-A in the Ia- 
resistant subpopulation. 
These experiments have shown that the Con-A-reactive T-cell population is Ia 
positive and is a  separate subpopulation from the PHA-responsive population, 
which is Ia negative. Target cells of both H-2 k and H-2 s gave identical results 
with appropriate anti-Ia serum and complement. 
Pretreatment with Anti-Ia Serum.  It was previously reported that pretreat- 
ment of  splenic lymphoid cells with anti-Ia serum without complement inhibited 
the in vitro humoral response to heterologous erythrocytes and the proliferative 
response to LPS (15, 16). Similar pretreatment of spleen cells with anti-Ia serum 
without complement before stimulation with T-cell mitogens, Con-A, and PHA 
had no effect on their response (Fig. 4 a and b). The anti-Ia serum used in these 
experiments was the A.TH anti-A.TL used above, which is known to have anti- 
T-cell cytotoxic activity (7). Such experiments were always performed with anti- 
H-2K and/or anti-H-2D sera, with normal serum, and with untreated cells as 
controls.  This experiment was repeated four times with identical results.  In 
addition to the PHA-M, Leucoagglutinin, a highly purified form of PHA, was 
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FIG. 2.  Con-A and PHA  (Leucoagglutinin) proliferative  response  of anti-Ia  ~  resistant 
B10.S (H-2')  spleen cells.  Spleen cells  were either  not treated  with serum and complement 
indicated  by NT, were treated  with  A.TL normal serum and complement indicated  by  A.TL- 
ns, or  treated  with A.TL a A.TH serum and complement indicated  by A.TL a A.TH. Equal 
numbers of  viable  cells  (5 x 105)  were cultured  for  72  h with  either  Con-A 1  #ag/ml,  open bars, 
or Leucoagglutinin  1 ~g/ml, shaded bars. Each bar represents the mean response of  four 
cultures  expressed as counts per minute -+ SD. The open bar at the left  of  the graph is  the 
background reponse in unstimulated cultures. 
Discussion 
Although it  has been accepted that Ia antigens are present on the membrane 
of  most B-lymphoid cells,  controversy has existed regarding their  expression on 
T  cells. We  have previously  reported  the absorption  of anti-Ia activity by 
thymocytes, direct  cytotoxic  reactivity  with cortisone-resistant  thymocytes, and 
levels  of  cytotoxicity  with spleen and lymph node cells  requiring lysis  of  at least 
a portion of T  cells  (7). Recently other investigators have reported evidence 
supporting the existence of  an la-positive  subpopulation of  T cells.  Most signifi- 
cant have been the demonstrations of  Ia-positive  thymocytes using the fluores- 
cence-activated cell  sorter  (18),  of  la sensitive Con-A activated thymocyte and 
splenic blasts (19,  20),  and of a characteristic  la peak of  30,000 tool  wt in the 
immunoprecipitation assay with thymus cells  (B. Schwartz, personal communi- 
cation). 
With anti-la  antibodies and complement it  has been possible to eliminate the 
Con-A response of spleen cells  and nylon-wood purified T cells.  However, the 
ability  to respond to another T-cell  mitogen PHA  and its more purified form, 
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Fro.  3.  Con-A-stimulated proliferative response of nylon-wool purified splenic T-cells. 
Splenic T-cells from B10.S (H-2") or B10.K (H-2 k) mice were treated with A.TH anti-A.TL 
serum (Ia  k) and complement. Equal numbers of viable cells (5 x  105) were cultured for 72 h 
with mitogen. The symbols represent: (©--O) nontreated splenic T-cells, (e--e)  anti-Ia  k 
serum treated B10.S cells, and (El--D) anti-Ia  k serum treated B10.K cells. Each point is the 
mean counts per minute of four cultures -+ SD. 
sensitive T cells are independent subpopulations with differential expression of 
Ia antigens. The removal of Con-A-sensitive cells by anti-Ia serum and comple- 
ment was more efficient when nylon-wool-purified  T cells were used. The need to 
increase the antibody concentration or to treat spleen cells a  second time with 
anti-Ia serum and complement may reflect a  lower density of the Ia antigens 
relative to other surface markers such as H-2 and Thy-1 on the T-cell membrane. 
The failure to  block  Con-A or  PHA  stimulation by simply incubating the 
spleen cells with anti-Ia antibodies is in contrast to the partial but significant 
inhibition of the proliferative response to several B-cell mitogens including LPS 
(16). The absence of mannose, the membrane binding sugar for Con-A, in the Ia 
antigen molecule may be significant to this observation. We interpret this lack 
of blocking to indicate that the receptors for these mitogens are distinct from Ia 
determinants on the cells membrane. 378  EFFECTS  OF  ANTI°IA  SERA  ON  MITOGENIC  RESPONSES 
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FIG. 4.  (a) Con-A proliferative response of B10.BR spleen cells at concentrations  of 0.1-10 
~g/ml. The cells were pretreated with anti-Ia serum for 30 min, washed ×2, and cultured for 
72 h with Con-A. The symbols represent the antiserum pretreatment: (O--O) no serum, 
(0--0) anti-Ia  k,  (V--V) anti-Ia  s,  and  (A_A)  anti.D  d.  Each  point  is the  mean of four 
cultures.  (b) PHA proliferative response of B10.BR spleen cells at concentrations  of 0.1-12 
/~g/ml. The cells were pretreated with anti-Ia serum for 30 min, washed x 2, and cultured for 
72 h  with PHA.  The symbols represent the antiserum pretreatment: (O--O) no serum, 
([~- D) anti-Ia  k, (V-~  anti-Ia  ~, and (A-A) anti.D d. Each point is the mean of four cul- 
tures. 
The removal of a  subset of T  cells which are sensitive to Con-A and distinct 
from PHA  reactive  Ia-negative  cells  is  consistent  with  the  findings  of other 
investigators concerning the existence of discrete T-cell subsets and the associa- 
tion of Ia determinants  and/or Ia-positive T  cells with certain T-cell functions. 
For example,  Cantor and  Boyse (21,  22)  and  Kisielow et al.  (23)  have demon- 
strated that "helper" T cells express LY-1, but not LY-23, which is expressed on 
"killer" T cells. Graft vs. host reactive cells, however, carry both LY-1 and LY-2 
surface  markers,  suggesting  the  existence  of at  least  three  T-cell subpopula- 
tions.  There  is  also  good  evidence  that  the  Ia  antigens  stimulate  in  mixed 
lymphocyte reaction,  and that the stimulating cell, but not the responding cell, 
can be blocked by anti-Ia sera (24). Lonai has been able to remove this stimulat- 
ing T cell by treatment with anti-Ia serum and complement (25). Of interest, too, 
is the finding that the activity of an antigen-specific helper cell replacing factor 
and an antigen-specific suppressor factor prepared from primed thymocytes can 
be removed by an Ia immunoabsorbent column (26-28). 
Recently we have found that we can inhibit the generation of Con-A-induced 
nonspecific  suppressor  T  cells  by  first  treating  spleen  cells  with  anti-Ia  and 
complement  before  culturing  with  Con-A  (Niederhuber,  unpublished  data). 
Once generated, the suppressor cells, however, are not sensitive to anti-Ia and 
complement treatment.  This  is  consistent  with  the  data  presented  here  and NIEDERHUBER  ET  AL.  379 
suggests that T  cells may express Ia only at certain times in their particular 
course of differentiation. David et al. have examined the Ia sensitivity of Con-A- 
activated thymocytes (19)  and find these cells to be easily lysed with  anti-Ia 
serum and complement when examined in dye exclusion and 51Cr cytotoxic tests. 
In  contrast,  Hauptfeld  et  al.  have  found  only  marginal  anti-Ia  serum  cyto- 
toxicity of Con-A-activated splenic lymphocytes, suggesting a  difference in the 
expression of Ia by thymus cells and peripheral T cells (20). 
We have previously observed that  when nylon-wool-purified splenic T  cells 
were  subjected  to  treatment  with  anti-Ia  serum  and  complement  in  a  dye 
exclusion microcytotoxic assay, negligible killing was observed (7). The ability 
to treat large numbers of such T  cells with anti-Ia  serum and complement to 
eliminate a functional property, such as the response to Con-A, would seem to be 
in  direct  conflict  to  these  earlier  cytotoxic  observations.  It  is  possible  that 
although the cells are not staining as dead cells in the cytotoxic assay, the cell 
membranes may be significantly damaged so that once the cells are cultured, 
they cannot respond normally and so are functionally killed. The second possibil- 
ity is that while antibody alone is not sufficient to block the Con-A binding site, 
antibody-complement complexes on the membrane might be sufficient blockers. 
Alternatively,  it  is  possible  that  only  a  small  number  of cells  are  actually 
activated by Con-A, and these cells recruit a large number of bystanding T cells 
to join  in  blast  transformation  and  proliferation.  Thus,  a  small  number  of 
sensitive  cells  could  easily  be  killed  by the  anti-Ia  serum  plus  complement 
treatment and not be detected, and in the absence of these Con-A sensitive cells, 
the cells normally recruited would not be induced to proliferate.  Experiments 
are currently in progress to examine this possibility. 
Although these experiments were performed with antibodies directed at multi- 
ple  specificities  within  the  entire  I  region,  they  clearly  show  that/-region 
products  are  expressed  on  T  cells,  and  that  a  pure  T-cell  function  can  be 
eliminated  by  using  anti-Ia  sera  and  complement  to  lyse  Ia-positive  cells. 
Preliminary  data using antisera  of restricted specificity suggest that not all I 
subregions code for antigens expressed on Con-A-reactive T cells (Niederhuber, 
unpublished). 
Summary 
Genes mapping in the I region of the H-2 complex control a system of lympho- 
cyte alloantigens (Ia) which are expressed on a subpopulation of T cells and on 
most B  cells.  Specific anti-Ia  serum in the presence of rabbit complement re- 
moved the splenic T-cell subpepulation responsive to Con-A, but did not affect 
the response to phytohemagglutinin (PHA) or Leucoagglutinin. Antibodies spe- 
cific for Ia, H-2K, or H-2D membrane antigens were used without complement 
to pretreat spleen cells. These antibody pretreated cells responded normally to 
Con-A and PHA. 
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